In specific, when two human lung cancer cell lines, A549 and PC-9, were treated with curcumin, a dose-dependent decrease in the expression of Akt and mTOR was observed as a result of the inhibition of hepatocyte growth factor (HGF) and its downstream effector c-Met [112]. Here, HGF is linked to lung cancer.